{"id":481466,"title":"Notice: Multiple Additions to the Prescription Drug List (PDL) [2024-04-30] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:45:22.987000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2024-04-30.html?wbdisable=true","snippet":"Notice: Multiple Additions to the Prescription Drug List (PDL) [2024-04-30] April 30, 2024 Our file number: 24-103562-165 The purpose of this Notice of Amendment is to notify about the addition of capivasertib, etrasimod and olipudase alfa to the Prescription Drug List (PDL) for…","rawSnapshotUrl":"/api/snapshots/raw/481466","browseUrl":"https://replay.healtharchive.ca/job-6/20260106164522/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2024-04-30.html?wbdisable=true#ha_snapshot=481466","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}